Результаты поиска - Cesar Dusilek

  • Отображение 1 - 15 результаты of 15
Отмена результатов
  1. 1
    Alterações histopatológicas associadas à braquiterapia intra-arterial com o samário-153

    Alterações histopatológicas associadas à braquiterapia intra-arterial com o samário-153 по Dalton Bertolim Précoma, Lúcia de Noronha, Álvaro Vieira Moura, Airton Seiji Yamada, José Knopfholz, Dario Hauer, Cesar Dusilek, Rita Perussolo, Márcia Olandoski, José Cláudio Meneghetti

    Опубликовано 2004
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    TCT-439 Long-term Savings with Telemedicine STEMI Networks

    TCT-439 Long-term Savings with Telemedicine STEMI Networks по Sameer Mehta, Roberto Botelho, Francisco D. Fernández Martín, Maurício Prudente, Ricardo Cavalcanti, Jamil Cade, Cesar Dusilek, Fausto Feres, Marco A. Alcocer‐Gamba, Alfredo Estrada, Mario Torres, Daniel Rodríguez, Haytham Aboushi

    Опубликовано 2018
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    P4491Telemedicine-guided STEMI networks - Pragmatic and cost-effective strategies for population-based AMI care in developing countries

    P4491Telemedicine-guided STEMI networks - Pragmatic and cost-effective strategies for population-based AMI care in developing countries по S. Mehta, Daniel Rodríguez, Roberto Botelho, Eduardo B. Fernández, Cesar Dusilek, Rodrigo de Franco Cardoso, Marcus Ernesto Sampaio Lacativa, Marco Perin, Fausto Feres, Alexandre Abizaid, Carlos M. Campos, R. Vega, F Bojanini, Marco Alcocer, Alfredo Estrada

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    TCT-394 Impact of Creating a Telemedicine-Guided, Population-Based, ST Elevation Myocardial Infarction (STEMI) Network on Revascularization Strategy, Cost and Mortality

    TCT-394 Impact of Creating a Telemedicine-Guided, Population-Based, ST Elevation Myocardial Infarction (STEMI) Network on Revascularization Strategy, Cost and Mortality по Sameer Mehta, Carlos M. Campos, Alex Au-Yeung, Adam Yoculan, Isaac Yepes, Roberto Botelho, Francisco D. Fernández Martín, R. Vega, Marco A. Alcocer‐Gamba, Juan Carlos Perez Alva, Marco Perin, Rodolfo Cardoso, Cesar Dusilek, Mario Torres, Daniel Rodríguez

    Опубликовано 2017
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study

    Effectiveness and tolerability of trimetazidine 80mg once daily in patients with chronic coronary syndrome: the V-GOOD observational study по L Wolff Gowdak, Priscila Leocádia Rosa Dourado, Dalton Bertolim Précoma, Cesar Dusilek, F Silva, Juan Carlos Yugar‐Toledo, Francisco Ayala de la Peña, D. Gomes, Elizabeth Do Esp Cestario, Octavio Guimaraes, C Hoffmann Filho, Cícero Almeida, Frederico Brito, Gustavo Celestino Martins, Vı́tor F. Ferreira

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    TCT-486 Critical Role of Stakeholders in STEMI Networks

    TCT-486 Critical Role of Stakeholders in STEMI Networks по Sameer Mehta, Roberto Botelho, Jamil Cade, Marco Perin, Maurício Prudente, Ricardo Cavalcanti, Cesar Dusilek, Rodolfo Cardoso, Nabil Hamdan, Luis I Calderón, Juan Carlos Perez Alva, Alfredo Estrada, Manuel Ibarra, Alejandro Ricalde, Alejandra Frauenfelder, Daniel Vieira, Mariana Ceschim, Genesis Del Nogal, P. Albert de la Cruz, Benjamin P. Wood, Akhil Vaid

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    TCT-501 Forging Partnerships for Constructing a Telemedicine-Guided, Nationwide STEMI Program for Mexico

    TCT-501 Forging Partnerships for Constructing a Telemedicine-Guided, Nationwide STEMI Program for Mexico по Sameer Mehta, Roberto Botelho, Jamil Cade, Marco Perin, Maurício Prudente, Ricardo Cavalcanti, Cesar Dusilek, Rodolfo Cardoso, Nabil Handam, Luis I Calderón, Marco A. Alcocer‐Gamba, Juan Carlos Perez Alva, Manuel Ibarra, Alfredo Estrada, Alejandro Ricalde, Alejandra Frauenfelder, Daniel Vieira, Gladys Pinto, Lorena Pisana, Anibal Munguia, Samantha Quintero, Maria Angelica Marin, Isabella Vallenilla, Carlos Peña, Genesis Del Nogal

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    TCT-506 LATIN - STEMI Prototype for Developing Countries

    TCT-506 LATIN - STEMI Prototype for Developing Countries по Sameer Mehta, Roberto Botelho, Jamil Cade, Marco Perin, Maurício Prudente, Ricardo Cavalcanti, Cesar Dusilek, Rodolfo Cardoso, Nabil Hamdan, Luis I Calderón, Marco A. Alcocer‐Gamba, Juan Carlos Perez Alva, Alfredo Estrada, Manuel Ibarra, Alejandro Ricalde, Alejandra Frauenfelder, Daniel Vieira, Gladys Pinto, Lorena Pisana, Jorge Mazzini, Anibal Munguia, I. Acosta-Colman, Maria Angelica Marin, Isabella Vallenilla, Carlos Peña, Maritza Luna

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    TCT-515 Marked Variability and Regional Constraints: Observations From a Population-Based and Telemedicine-Guided STEMI Program

    TCT-515 Marked Variability and Regional Constraints: Observations From a Population-Based and Telemedicine-Guided STEMI Program по Sameer Mehta, Daniel Vieira, Roberto Botelho, Jamil Cade, Marco Perin, Maurício Prudente, Ricardo Cavalcanti, Cesar Dusilek, Rodolfo Cardoso, Nabil Hamdan, Luis I Calderón, Marco A. Alcocer‐Gamba, Juan Carlos Perez Alva, Alfredo Estrada, Manuel Ibarra, Alejandro Ricalde, Alejandra Frauenfelder, Gladys Pinto, Lorena Pisana, Jorge Mazzini, Samantha Quintero, Claudia Lopez, Isabella Vallenilla, Carlos Peña, Genesis Del Nogal, Jorge Cárdenas

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study

    Effectiveness and Tolerability of Trimetazidine 80 mg Once Daily in Patients with Chronic Coronary Syndrome in Brazil: The V-GOOD Observational Study по Luís Henrique Wolff Gowdak, Paulo Magno Martins Dourado, Dalton Bertolim Précoma, Cesar Dusilek, Francisco Maia da Silva, Juan Carlos Yugar‐Toledo, Felipe Montes Pena, D. Gomes, Elizabeth do Espírito Santo Cestário, Octavio Guimaraes, Conrado Roberto Hoffmann Filho, Cícero Almeida, Flávio de Souza Brito, Gerez Fernandes Martins, Victor Rodrigues Ribeiro Ferreira, Marcella Flores, Mayara Lídia da Silva

    Опубликовано 2025
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)

    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random... по Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati, Fernando Crivelenti Vilar, Anna Christina Tojal da Silva, Paulo Louzada‐Júnior, Benedito Antônio Lopes da Fonseca, Hayala Cristina Cavenague de Souza, Caroline Candida Carvalho de Oliveira, Valéria Cristina Resende Aguiar, Carlos Augusto de Aguiar Quadros, Cesar Dusilek, Kengi Itinose, Ricardo Risson, Lucas Roberto Rivabem Ferreira, Renato D. Lópes, Esper G. Kallás, Fernando Bellissimo‐Rodrigues

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors)

    Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot random... по Lívia Pimenta Bonifácio, Eduardo Ramacciotti, Leandro Barile Agati, Fernando Crivelenti Vilar, Anna Christina Tojal da Silva, Paulo Louzada‐Júnior, Benedito Antônio Lopes da Fonseca, Hayala Cristina Cavenague de Souza, Caroline Candida Carvalho de Oliveira, Valéria Cristina Resende Aguiar, Carlos Augusto de Aguiar Quadros, Cesar Dusilek, Kengi Itinose, Ricardo Risson, Lucas Roberto Rivabem Ferreira, Renato D. Lópes, Esper G. Kallás, Fernando Bellissimo‐Rodrigues

    Опубликовано 2023
    Полный текст
    Conjunto de Dados
    Добавить в Избранное
    Сохранить в:
  13. 13
    Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial

    Medically Ill hospitalized Patients for COVID-19 THrombosis Extended ProphyLaxis with rivaroxaban ThErapy: Rationale and Design of the MICHELLE Trial по Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Giuliano Giová Volpiani, Caroline Candida Carvalho de Oliveira, Valéria Cristina Resende Aguiar, Elizabeth Rodrigues, Marcone Lima Sobreira, Edwaldo Édner Joviliano, Cesar Dusilek, Kenji Itinose, Rogério Aparecido Dedivitis, André Sementilli Cortina, Suzanna Maria Viana Sanches, Nara Franzin de Moraes, Paulo Fernando Guimarães Morando Marzocchi Tierno, André Luiz Malavasi Longo de Oliveira, Adriano Tachibana, Rodrigo Caruso Chate, Marcus Vinícius Barbosa Santos, Bruno Bezerra de Menezes Cavalcante, Ricardo Moreira, Chang Chiann, Alfonso Tafur, Alex C. Spyropoulos, Renato D. Lópes

    Опубликовано 2021
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

    Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial по Huijie Bian, Liang Chen, Zhaohui Zheng, Xiuxuan Sun, Jiejie Geng, Ruo Chen, Ke Wang, Xu Yang, Shirui Chen, Siyu Chen, Xie Rong-hua, Kui Zhang, Jinlin Miao, Junfeng Jia, Hao Tang, Shuangshuang Liu, Hongwei Shi, Yong Yang, Xiaochun Chen, Vinay Malhotra, Nosheen Nasir, Iffat Khanum, Faisal Mahmood, Saeed Hamid, Claudio Stadnik, Kengi Itinose, Caroline Cândida Carvalho de Oliveira, Cesar Dusilek, Lucas Rivabem, Adilson Joaquim Westheimer Cavalcante, Suzara Souto Lopes, Wladmir Faustino Saporito, Fábio José Concilio Fucci, Jesus Abraham Simón Campos, Ling Wang, Linna Liu, Qingyi Wang, Wei Ding, Zheng Zhang, Zhi‐Nan Chen, Ping Zhu

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial

    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial по Eduardo Ramacciotti, Leandro Barile Agati, Daniela Calderaro, Valéria Cristina Resende Aguiar, Alex C. Spyropoulos, Caroline Candida Carvalho de Oliveira, Jessica Lins dos Santos, Giuliano Giová Volpiani, Marcone Lima Sobreira, Edwaldo Édner Joviliano, Milton Sérgio Bohatch Júnior, Benedito Antônio Lopes da Fonseca, Maurício Serra Ribeiro, Cesar Dusilek, Kengi Itinose, Suzanna Maria Viana Sanches, Karine de Almeida Araújo Ramos, Nara Franzin de Moraes, Paulo Fernando Guimarães Morando Marzocchi Tierno, André Luiz Malavasi Longo de Oliveira, Adriano Tachibana, Rodrigo Caruso Chate, Marcus Vinícius Barbosa Santos, Bruno Bezerra de Menezes Cavalcante, Ricardo Moreira, Chang Chiann, Alfonso Tafur, Jawed Fareed, Renato D. Lópes, Tania Benevenuto Caltabiano, B Hattori, Marcello da Silva Jardim, Igor Maia Marinho, Ivan S. Marinho, Liane Mara Melo Batista, Lucas Rivabem, Carlos Alberto Kenji Nakashima, Ana Carla Gois Franco, Renata Fernanda de Oliveira Pereira, Giana Caroline Strack Neves, Izara de Castro e Souza, Bruno Moraes Ribas, Flavia Ramos Tristão, Marcus Vinícius Barbosa Santos

    Опубликовано 2021
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: